This Solicitation opportunity from Department Of Defense was posted on June 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SCOPOLAMINE TRANSDE
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement of Scopolamine Transdermal patches, identified by the National Stock Number 6505-01-692-5042, with a quantity of one unit requested. The solicitation, numbered SPE2DP-26-T-3627, was issued by the Defense Logistics Agency under the Department of Defense. The solicitation was posted on June 1, 2026, and responses were due by June 8, 2026. This acquisition falls under a federal organization, reflecting the government's intent to source this medical product through a formal solicitation process. Specific details such as the exact place of performance, type of set-aside, and NAICS code are not provided, and there is no designated point of contact listed in the contract data. The solicitation aims to fulfill a purchase request referenced as 7016979466, and further information and submission opportunities are accessible through the official Defense Logistics Agency online portal. The contract underscores the government’s procurement of a critical pharmaceutical item for defense-related use.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
